Clinical Benefit From Neoadjuvant Chemotherapy in Oestrogen Receptor-Positive Invasive Ductal and Lobular Carcinomas

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2012.557
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Comparison of Clinical Outcomes Between Luminal Invasive Ductal Carcinoma and Luminal Invasive Lobular Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Clinical Significance and Prognostic Value of Receptor Conversion in Hormone Receptor Positive Breast Cancers After Neoadjuvant Chemotherapy

World Journal of Surgical Oncology
SurgeryOncology
2018English

PB.04: MRI in Lobular and Mixed Lobular/Ductal Carcinomas: Can We Preselect Cases Based on Imaging Appearance?

Breast Cancer Research
Cancer ResearchOncology
2013English

Increased Mortality in HER2 Positive, Oestrogen Receptor Positive Invasive Breast Cancer: A Population-Based Study

British Journal of Cancer
Cancer ResearchOncology
2010English

Metallothionein 1E mRNA Is Highly Expressed in Oestrogen Receptor-Negative Human Invasive Ductal Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2000English

Differences Between Invasive Lobular and Invasive Ductal Carcinoma of the Breast: Results and Therapeutic Implications

Therapeutic Advances in Medical Oncology
Oncology
2016English

Invasive Lobular Carcinomas of the Breast – The Prognosis of Histopathological Subtypes

British Journal of Cancer
Cancer ResearchOncology
1989English

Relevance of Systems Biological Approach in the Differential Diagnosis of Invasive Lobular Carcinoma & Invasive Ductal Carcinoma

Bioinformation
2012English

Oestrogen Receptor-Negative/Progesterone Receptor-Positive Phenotype of Invasive Breast Carcinoma in Japan: Re-Evaluated Using Immunohistochemical Staining

Breast Cancer
Nuclear MedicineRadiologyPharmacologyOncologyImagingMedicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy